PROM1 and breast carcinoma: Epigenetic changes (DNA methylation, acetylation, chromatin modification, microRNA, etc.)have also been correlated with CD133 in TNBC breast cancer stem cells, possibly related to the nuclear localization of this glycoprotein [29].